eXmoor Pharma

Bristol, United Kingdom
Find alternatives to eXmoor Pharma for Cell Therapy →
Program data pending ClinicalTrials.gov matching · Last scored 2026-10-29
78.1
Signal Score
○ FDA Inspections ○ Clinical Trials ○ SEC Filings ✓ Press (3) ○ EMA GMP ✓ MHRA GMP (1)

Quick Facts: eXmoor Pharma

Signal Score
78.1/100 (as of 2026-10-29)
Quality Compliance
100.0/100
Headquarters
Bristol, United Kingdom
Modalities
Cell Therapy, AAV
Active Programs
No ClinicalTrials.gov matches confirmed — 1 partnership signal in press (announcements, not verified)
Data Sources
FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring
Scored By
CDMO Signal — independent CDMO intelligence platform

About eXmoor Pharma

Pure-play CDMO.

Signal Score & Pillar Breakdown

Quality Compliance 100.0
FDA InspectionsNo US records on file
MHRA GMP Certificates1 on record
Operations —
No ClinicalTrials.gov facility matches confirmed for this manufacturer. 1 partnership announcement found in press monitoring.
Programs — no verified data
Sponsors— no verified data
ModalitiesCell Therapy, AAV
No clinical trial matches found for this manufacturer
Operational score requires ClinicalTrials.gov data
Scored from ClinicalTrials.gov and FDA records; SEC EDGAR and press items are shown as company signals, not scored. No unverified estimates shown.
Partnership Signals (from press monitoring)
Company announcements, not verified evidence.
Financial Stability 60.0
Private company
Financial assessment: 60.0/100
Source: company profile (public/private status, parent company)
Profile-based financial assessment
SEC FilingsPrivate company
Private company
Financial assessment: 60.0/100
Capacity 58.0
1 manufacturing site: Bristol, UK
Modalities: Cell Therapy, AAV
Capacity assessment: 58.0/100
Sites: Bristol, UK
Source: company profiles (manufacturing sites, modality breadth)
1 manufacturing site
Press Signals3 articles (not scored)
1 manufacturing site: Bristol, UK
Modalities: Cell Therapy, AAV
Capacity assessment: 58.0/100

eXmoor Pharma MHRA GMP Compliance 1 certificates

2025-11
Compliant Non-Compliant
Certificate Site City / Postcode Inspection Date Status
UK MIA(IMP) 32954 Insp GMP/IMP 32954/36082496-0002[I] EXMOOR PHARMA CONCEPTS LTD BRISTOL BS34 5TA 2025-11-12 COMPLIANT
Source: MHRA GMDP Database · Retrieved Nov 22, 2026

Hiring Activity Beta

Built from public job postings when a company's own roles can be read. Job postings are signals, not statements by the company; each one below links to the original. How we collect this
No hiring data yet. We haven't found a public jobs feed for this company.
Source: public careers pages · Checked Nov 21, 2026

Company Signals 3 articles

Company announcements, not verified evidence. They do not change any score.
partnership 2026-04-10
eXmoor Pharma and Royal Free London’s CVIC Form Strategic Partnership to Streamline UK Cell and Gene Therapy Manufacturing - BioPharma APAC
eXmoor Pharma and Royal Free London’s CVIC Form Strategic Partnership to Streamline UK Cell and Gene Therapy Manufacturing  BioPharma APAC
general 2026-03-06
eXmoor Pharma appoints Manuel Balbuena as Chief Commercial Officer - Pharmafile
eXmoor Pharma appoints Manuel Balbuena as Chief Commercial Officer  Pharmafile
general 2026-03-03
eXmoor Pharma Appoints Manuel Balbuena Chief Commercial Officer - Contract Pharma
eXmoor Pharma Appoints Manuel Balbuena Chief Commercial Officer  Contract Pharma

Frequently Asked Questions About eXmoor Pharma

Does eXmoor Pharma hold EMA or MHRA GMP certificates?
CDMO Signal tracks 1 MHRA GMP certificate for eXmoor Pharma.
What is eXmoor Pharma's CDMO Signal Score?
eXmoor Pharma has a Signal Score of 78/100, based on quality, operations, financial stability, and capacity data.
Evaluating eXmoor Pharma for a manufacturing program?
Use the free AI matchmaker to compare eXmoor Pharma against other CDMOs by FDA, EMA, and clinical-trial data — no login required.
Find & compare CDMOs →
Represent this organization? Contact us to verify or update this profile.
See all CDMOs in:
Cell Therapy CDMOs → AAV CDMOs →

Similar CDMOs

Rose BioSolutions
Rockville, MD · Memphis, TN · Keele, United Kingdom
Signal Score: 64.0
AAV, Lentiviral, Adenoviral, Plasmid, Cell Therapy, CAR-T
Cell and Gene Therapy Catapult
Stevenage, United Kingdom
Signal Score: 59.0
CAR-T, Cell Therapy, AAV
Charles River Laboratories
Newbury Park, CA · Memphis, TN · Keele, UK · Rockville, MD
Signal Score: 86.3
CAR-T, Cell Therapy, Gene Editing, Plasmid, AAV, Lentiviral, ADC
Takeda
Boston, MA · Zurich, CH
Signal Score: 83.4
AAV, Cell Therapy
WuXi Biologics
Shanghai, CN · Wuxi, CN
Signal Score: 82.7
CAR-T, Cell Therapy, AAV, ADC, Monoclonal Antibody

Compare eXmoor Pharma with another CDMO

Side-by-side scoring, FDA inspection history, EMA/MHRA GMP coverage, and clinical-program footprint.
Compare side-by-side
See two CDMOs' scoring, inspection history, and clinical footprint next to each other.
Open comparison →
Run a sourcing search
Describe your program's requirements — Signal matches CDMOs against FDA, EMA/MHRA, ClinicalTrials.gov and capacity signals.
Search for a CDMO →
Get updates on eXmoor Pharma
Get an email when a CDMO on this list has a new FDA inspection, GMP certificate, or scoring change.